Colin Hutton

1.1k total citations
9 papers, 363 citations indexed

About

Colin Hutton is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Colin Hutton has authored 9 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Colin Hutton's work include Immune cells in cancer (3 papers), PARP inhibition in cancer therapy (2 papers) and Carbohydrate Chemistry and Synthesis (1 paper). Colin Hutton is often cited by papers focused on Immune cells in cancer (3 papers), PARP inhibition in cancer therapy (2 papers) and Carbohydrate Chemistry and Synthesis (1 paper). Colin Hutton collaborates with scholars based in United Kingdom, Netherlands and India. Colin Hutton's co-authors include Adrián Blanco‐Gómez, Claus Jørgensen, Donald Ogilvie, Emma Fairweather, Ian D. Waddell, Allan M. Jordan, James R. Hitchin, Ton N. Schumacher, Victoria S. Pelly and Santiago Zelenay and has published in prestigious journals such as Nature Communications, Nature Biotechnology and Cancer Research.

In The Last Decade

Colin Hutton

8 papers receiving 361 citations

Peers

Colin Hutton
Nikhil Hebbar United States
Kaustubh N. Bhinge United States
Su‐Fern Tan United States
Lanya Li China
L. Serrone Malaysia
Kaamar Azijli Netherlands
Vito W. Rebecca United States
Pamela Rutherford United States
Eimear Flanagan United Kingdom
Nikhil Hebbar United States
Colin Hutton
Citations per year, relative to Colin Hutton Colin Hutton (= 1×) peers Nikhil Hebbar

Countries citing papers authored by Colin Hutton

Since Specialization
Citations

This map shows the geographic impact of Colin Hutton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Hutton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Hutton more than expected).

Fields of papers citing papers by Colin Hutton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Hutton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Hutton. The network helps show where Colin Hutton may publish in the future.

Co-authorship network of co-authors of Colin Hutton

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Hutton. A scholar is included among the top collaborators of Colin Hutton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Hutton. Colin Hutton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Fowler, Daniel, Colin Hutton, Jahangir Sufi, et al.. (2025). Phenoscaping Reveals Multimodal γδ T-cell Cytotoxicity as a Strategy to Overcome Cancer Cell–Mediated Immunomodulation. Cancer Research. 85(22). 4415–4432.
2.
Hutton, Colin & Vivian Li. (2024). A mini-colon models colon cancer and its microenvironment. Nature Biotechnology. 43(5). 686–688. 1 indexed citations
3.
Novellasdemunt, Laura, Anna Baulies, Colin Hutton, et al.. (2023). USP7 inactivation suppresses APC-mutant intestinal hyperproliferation and tumor development. Stem Cell Reports. 18(2). 570–584. 10 indexed citations
4.
Pelly, Victoria S., Agrin Moeini, Lisanne M. Roelofsen, et al.. (2021). Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy. Cancer Discovery. 11(10). 2602–2619. 117 indexed citations
5.
Lee, Brian Y., Elizabeth Hogg, Alexander Kononov, et al.. (2021). Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis. Nature Communications. 12(1). 7336–7336. 64 indexed citations
6.
Small, Helen, Kate M. Smith, Alison E. McGonagle, et al.. (2019). Fluoromethylcyclopropylamine derivatives as potential in vivo toxicophores – A cautionary disclosure. Bioorganic & Medicinal Chemistry Letters. 29(4). 560–562. 1 indexed citations
7.
Waszkowycz, Bohdan, Kate M. Smith, Alison E. McGonagle, et al.. (2018). Cell-Active Small Molecule Inhibitors of the DNA-Damage Repair Enzyme Poly(ADP-ribose) Glycohydrolase (PARG): Discovery and Optimization of Orally Bioavailable Quinazolinedione Sulfonamides. Journal of Medicinal Chemistry. 61(23). 10767–10792. 26 indexed citations
8.
James, Dominic I., Kate M. Smith, Allan M. Jordan, et al.. (2016). First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to Olaparib. ACS Chemical Biology. 11(11). 3179–3190. 94 indexed citations
9.
Hitchin, James R., Julian Blagg, Rosemary Burke, et al.. (2013). Development and evaluation of selective, reversible LSD1 inhibitors derived from fragments. MedChemComm. 4(11). 1513–1513. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026